Background In order to increase eradication rates, vonoprazan, a novel potassium‐
competitive acid blocker, has been used in Helicobacter pylori eradication therapy. Aim To …

Background Due to clarithromycin resistance, the current efficacy of Helicobacter pylori first-
line triple therapies including clarithromycin is low. It seems reasonable to explore …

Abstract Background The efficacy of Helicobacter pylori eradication regimens may depend
on the country where the studies were performed because of the difference in antibiotic …

Methods We retrospectively reviewed data from patients who received first-line treatment for
H. pylori infection using tegoprazan-or rabeprazole-based triple therapy for 2 weeks (50 mg …

Peptic ulcer (PU) is the most common disease of gastrointestinal tract (GIT) which affects the
stomach and duodenum. It is characterized by an imbalance between the aggressive and …

Helicobacter pylori (H. pylori) is known to be associated with many gastrointestinal diseases
including peptic ulcer. In Korea, eradication of H. pylori is recommended for peptic ulcer …

Introduction The efficacy of currently recommended third‐line therapies for Helicobacter
pylori is suboptimal, even that of culture‐guided treatments. Resistance to multiple …

Significant progress and new insights have been gained since Helicobacter pylori was
found in 1982. Even with currently most effective treatment regimen, about 10-20% of …

Helicobacter pylori is a gram-negative bacterium that was first isolated in 1982. Since then,
H. pylori infection in humans has been shown to be associated with gastritis, peptic ulcer …

Helicobacter pylori infection is one of the most common gastrointestinal infectious diseases
in Korea and is related to diseases such as gastritis, peptic ulcer disease, marginal zone B …